Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity -Schedule of Warrant Activity (Details)

v3.20.2
Stockholders' Equity -Schedule of Warrant Activity (Details)
9 Months Ended
Sep. 30, 2020
$ / shares
shares
Equity [Abstract]  
Warrants Outstanding, Beginning | shares 461,647
Warrants Assumed as Part of the Merger | shares 413,449
Warrants Granted | shares 5,520,807
Warrants Exercised | shares (4,371,492)
Warrants Outstanding, Ending | shares 2,024,411
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 7.33
Weighted Average Exercise Price Assumed as Part of the Merger | $ / shares 14.11
Weighted Average Exercise Price Granted | $ / shares 1.18
Weighted Average Exercise Price Exercised | $ / shares 0.74
Weighted Average Exercise Price Outstanding, Ending | $ / shares $ 6.17
Weighted Average Remaining Contractual Life, Beginning 4 years 2 months 19 days
Weighted Average Remaining Contractual Life, Ending 4 years 2 months 1 day